Systematic Review
Copyright ©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6016-6024
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6016
Table 1 Characteristics of the included studies
AuthorsCountryYear of publicationNumber of patientsNOSaLiver cirrhosis
Alvarez et al[10]Buenos Aires, Argentina201530IN
Chan et al[5]Hong Kong, China201625IY
Linecker et al[11]Zurich, Switzerland201745IN
Petrowsky et al[4]Zurich, Switzerland201524IN
Table 2 Outcomes of FLR hypertrophy rate, morbidity and mortality in each included study
AuthorsFLR hypertrophy
Morbidity
Mortality
ALPPSp-ALPPSALPPSp-ALPPSALPPSp-ALPPS
Alvarez et al[10]107% (12.2)90% (20.8)8 (9)8 (21)1 (9)1 (21)
Chan et al[5]--1 (13)3 (12)0 (13)2 (12)
Linecker et al[11]61% (15)64.5% (12.1)8 (22)3 (23)7 (22)0 (23)
Petrowsky et al[4]--12 (18)2 (6)4 (18)0 (6)